Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
- PMID: 10884226
- DOI: 10.1126/science.289.5476.119
Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
Abstract
Hypertension and pregnancy-related hypertension are major public health problems of largely unknown causes. We describe a mutation in the mineralocorticoid receptor (MR), S810L, that causes early-onset hypertension that is markedly exacerbated in pregnancy. This mutation results in constitutive MR activity and alters receptor specificity, with progesterone and other steroids lacking 21-hydroxyl groups, normally MR antagonists, becoming potent agonists. Structural and biochemical studies indicate that the mutation results in the gain of a van der Waals interaction between helix 5 and helix 3 that substitutes for interaction of the steroid 21-hydroxyl group with helix 3 in the wild-type receptor. This helix 5-helix 3 interaction is highly conserved among diverse nuclear hormone receptors, suggesting its general role in receptor activation.
Comment on
-
Hypertension. Mutation points to salt recycling pathway.Science. 2000 Jul 7;289(5476):23-6. doi: 10.1126/science.289.5476.23b. Science. 2000. PMID: 10928921 No abstract available.
Similar articles
-
Hypertension. Mutation points to salt recycling pathway.Science. 2000 Jul 7;289(5476):23-6. doi: 10.1126/science.289.5476.23b. Science. 2000. PMID: 10928921 No abstract available.
-
The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related.Endocrinology. 2003 Feb;144(2):528-33. doi: 10.1210/en.2002-220708. Endocrinology. 2003. PMID: 12538613
-
Identification of steroid ligands able to inactivate the mineralocorticoid receptor harboring the S810L mutation responsible for a severe form of hypertension.Mol Cell Endocrinol. 2004 Mar 31;217(1-2):181-8. doi: 10.1016/j.mce.2003.10.053. Mol Cell Endocrinol. 2004. PMID: 15134816
-
Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors.J Steroid Biochem Mol Biol. 2013 Sep;137:57-70. doi: 10.1016/j.jsbmb.2013.07.009. Epub 2013 Jul 29. J Steroid Biochem Mol Biol. 2013. PMID: 23907018 Review.
-
[Genetic disorders caused by gain or loss of function of the mineralocorticoid receptor].Nihon Rinsho. 2002 Feb;60(2):361-6. Nihon Rinsho. 2002. PMID: 11857927 Review. Japanese.
Cited by
-
A narrative review of Hyporeninemic hypertension-an indicator for monogenic forms of hypertension.Pediatr Med. 2022 May;5:21. doi: 10.21037/pm-21-48. Epub 2022 May 28. Pediatr Med. 2022. PMID: 36325202 Free PMC article.
-
Epithelial Na(+) channel regulation by cytoplasmic and extracellular factors.Exp Cell Res. 2012 May 15;318(9):1011-9. doi: 10.1016/j.yexcr.2012.02.024. Epub 2012 Mar 3. Exp Cell Res. 2012. PMID: 22405998 Free PMC article. Review.
-
The Pharmacogenomics of Anti-Hypertensive Therapy.Pharmaceuticals (Basel). 2010 Jun 1;3(6):1779-1791. doi: 10.3390/ph3061779. Pharmaceuticals (Basel). 2010. PMID: 27713329 Free PMC article. Review.
-
A rare case of hyporeninemic hypertension: Answers.Pediatr Nephrol. 2021 Mar;36(3):569-573. doi: 10.1007/s00467-020-04667-4. Epub 2020 Jun 30. Pediatr Nephrol. 2021. PMID: 32607771 Free PMC article. No abstract available.
-
Arterial hypertension with brachydactyly in a 15-year-old boy.Pediatr Nephrol. 2003 Aug;18(8):814-9. doi: 10.1007/s00467-003-1169-2. Epub 2003 Jun 13. Pediatr Nephrol. 2003. PMID: 12811651
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases